Epidemiological analysis of the 2006 bluetongue virus serotype 8 epidemic in north-western Europe. Within herd distribution of infection

Similar documents
Seroprevalence of antibodies to Schmallenberg virus in livestock

BLUETONGUE The Netherlands 2006

Epidemiological analysis of the 2006 bluetongue virus serotype 8 epidemic in north-western Europe. Nature and severity of disease in sheep and cattle

Eradication and monitoring programme for Bluetongue

EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL. Unit G5 - Veterinary Programmes

Bluetongue in Albania. Ardian XINXO Deputy Director of Food Safety and Veterinary Institute - MARDWA

Bluetongue virus serotype 8 in sheep and cattle: a clinical update

HEALTH REGULATIONS RELATED TO ANIMALS ADMISSION TO THE EUROPEAN HOLSTEIN CHAMPIONSHIP IN COLMAR, FRANCE, FROM 14 TO 19 JUNE 2016

RISK ASSESSMENT WORKPACKAGE 5 BTV OVERWINTERING BY HORIZONTAL TRANSMISSION IN VECTORS, RUMINANTS OR IN BOTH

Surveillance of animal brucellosis

Wageningen Bioveterinary Research. Biomedical and veterinary research to safeguard animal and public health

Use of monthly collected milk yields for the early detection of vector-borne emerging diseases.

Ticks and tick-borne pathogens Jordi Tarrés-Call, Scientific Officer of the AHAW unit

Detecting new diseases such as Schmallenberg Virus infections (SBV) Guda van der Burgt, Veterinary Investigation Officer AHVLA Luddington

Peste des Petits Ruminants. Articles of the OIE Terrestrial Manual and Terrestrial Code related to PPR. Joseph Domenech, OIE

WAGENINGEN UNIVERSITY LABORATORY OF ENTOMOLOGY

Schmallenberg Virus Infections in Ruminants

Cercetări bacteriologice, epidemiologice şi serologice în bruceloza ovină ABSTRACT

Import Health Standard. For. Bovine Semen

21st Conference of the OIE Regional Commission for Europe. Avila (Spain), 28 September 1 October 2004

Presentation Outline. Commercial RVF vaccines. RVF Clone 13 performance in the field. Candidate RVF vaccines in the pipeline

Final Technical Report on the Proposal PGTF- INT/11/K07, PROG/2011/172.

Economic analysis of some emerging infectious diseases for the Dutch livestock sector - A pilot study Minor Thesis Business Economics

Assignment 13.1: Proofreading Bovine Spongiform Encephalopathy

PREVALENCE OF BORDER DISEASE VIRUS ANTIBODIES AMONG NATIVE AND IMPORTED SHEEP HERDS IN ZABOL. Sari-Iran.

CSF Position on Blue Tongue and Anaplasmosis Import Regulations with respect to U.S. trade.

MATTILSYNET NORWEGIAN FOOD SAFETY AUTHORITY

MATTILSYNET THE NORWEGIAN FOOD SAFETY AUTHORITY

Food borne diseases: the focus on Salmonella

Diseases of Small Ruminants and OIE Standards, Emphasis on PPR. Dr Ahmed M. Hassan Veterinary Expert 7 9 April, 2009 Beirut (Lebanon)

An Overview of Camelids in the United States. Patrick Long DVM Camelid Healthcare Services Corvallis Oregon

FESASS General Assembly, 22 September 2011, Brussels. Financial aspects of infectious animal disease control and eradication

Cross-sectional serosurvey and associated factors of bluetongue virus antibodies presence in small ruminants of Nepal

Transmission of the virus (SBV) Stéphan Zientara UMR 1161 ANSES/INRA/ENVA

EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL. Unit G5 - Veterinary Programmes

Seroprevalence of Bluetongue among domestic ruminants in Northern Kerala, India

VETERINARY CERTIFICATE FOR IMPORT OF GOATS INTO INDIA

Bluetongue disease and seroprevalence in South American camelids from the northwestern region of the United States

ANNEX. to the. Commission Implementing Decision

Histomoniasis. Diagnosis, Prophylaxis, Treatment - Research developments. Koen De Gussem, DVM Parma, 22/01/2013

Eradication and monitoring programme for Bluetongue

Country report: aquatic animal health management in Thailand

EFSA Scientific Opinion on canine leishmaniosis

Veterinary Emergency Intervention

OIE Collaborating Centres Reports Activities

Peste des Petits Ruminants

VETERINARY SERVICES ACT (CAP. 437) Animal Health Conditions Governing Intra-Community Trade in Ovine and Caprine Animals Rules, 2004

of Conferences of OIE Regional Commissions organised since 1 June 2008

Zoonoses in food and feed

BLUETONGUE CONTINGENCY PLAN FOR THE NETHERLANDS

OIE international standards on Rabies:

Modelling animal movement patterns for disease impact assessment rationale and implications of the FLI/DTU EuFMD-FAR project

OIE Reference Laboratory Reports Activities

Overview of animal and human brucellosis in EU: a controlled disease?

STEPHEN N. WHITE, PH.D.,

READER S DIGEST OVERVIEW: BIGHORN SHEEP. Peregrine Wolff, DVM

DISEASE DETECTION OF BRUCELLOSIS IN GOAT POPULATION IN NEGERI SEMBILAN, MALAYSIA. Abstract

Index. Note: Page numbers of article titles are in boldface type.

Greek Rabies Eradication Program. Greek Rabies Eradication Program. Department of Zoonoses

Standing Group of Experts on Lumpy Skin Disease in Europe under the GF-TADs umbrella

A LABORATORY NETWORK FOR DIAGNOSTIC OF CAMELIDS DISEASES

If encountering difficulties, please contact describe the issue and mention the version of this document:

Livestock Identification / Registration among the West Eurasia Countries. Results of a Survey

Rabies in the Slovak Republic

Transboundary Animal Diseases. Katinka de Balogh Senior Officer-Veterinary Public Health Animal Health Service

ANNEX. to the COMMISSION IMPLEMENTING DECISION

Surveillance. Mariano Ramos Chargé de Mission OIE Programmes Department

Implementation of Bovine and Small Ruminant s Brucellosis Eradication Programmes in Portugal PAFF Standing Committee Brussels, 8 June 2017

Protocol between the General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China and the

Classificatie: intern

PESTE DES PETITS RUMINANTS (PPR) IN SAIGA ANTELOPE IN MONGOLIA

Veterinary Expenditures

Premium Sheep and Goat Health Scheme Rules for Johne s Disease

Guidance Document. Pig Semen PIGSEMEN.GEN. [Document Date] A guidance document issued by the Ministry for Primary Industries

Regional research activities and state of the art of Vmerge Project: Emerging viralvector

GLOSSARY. Annex Text deleted.

OIE Collaborating Centres Reports Activities

NIAA Resolutions Bovine Committee

Marc Widmer successfully defends WA from European wasp. and the environment. Susan Campbell. Supporting your success

Albania Inception workshop of the project

Dengue Situation Update Number November 2016

NATIONAL PLAN FOR FISH HEALTH MANAGEMENT Submitted by:

OIE international standards on Rabies: Movement of dogs,, vaccination and vaccines

Standard requirements for the submission of programmes of eradication and monitoring of TSE

Diseases of Concern: BVD and Trichomoniasis. Robert Mortimer, DVM Russell Daly, DVM Colorado State University South Dakota State University

Brucellosis in Kyrgyzstan

OPPORTUNITIES FOR GENETIC IMPROVEMENT OF DAIRY SHEEP IN NORTH AMERICA. David L. Thomas

Drd. OBADĂ MIHAI DORU. PhD THESIS ABSTRACT

Global Perspective of Rabies. Alexander I. Wandeler CFIA Scientist Emeritus

Hyalomma impeltatum (Acari: Ixodidae) as a potential vector of malignant theileriosis in sheep in Saudi Arabia

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Ren Tip # 84 11/6/15

Research Article Seroprevalence of Bluetongue Virus in Dairy Herds with Reproductive Problems in Sudan

The undersigned Official Veterinarian certifies that the animal/s described above and examined on this day:

CONTAGIOUS BOVINE PLEURO- PNEUMONIA steps towards control of the disease. Rose Matua -Department of Veterinary Services, Kenya

The BVA submission on Responsibility and Cost Sharing for Animal Health and Welfare

(Non-legislative acts) DECISIONS

COMMISSION OF THE EUROPEAN COMMUNITIES REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL

Country Report Malaysia. Norazura A. Hamid Department of Veterinary Services, Malaysia

Culicoides and the global epidemiology of bluetongue virus infection

Transcription:

Epidemiological analysis of the 26 bluetongue virus serotype 8 epidemic in north-western Europe Within herd distribution of infection A.R.W. Elbers 1, K. Mintiens 2, G. Gerbier 3, A.N. van der Spek 4, E. Meroc 2, S. Zientara 5, P.A. van Rijn 1 1 CIDC-Lelystad of Wageningen University and Research Centre, The Netherlands; 2 VAR-CODA-CERVA, Belgium; 3 CIRAD, France; 4 Food and Consumer Product Safety Authority, The Netherlands; 5 AFSSA, France. 1/9

Introduction and Objectives For the development of surveillance programs in the aftermath of the epidemic it is important to know what is to be expected on the distribution of infection within livestock herds. Livestock herds are epidemiological units within geographical compartments in a country from which (sentinel) animals are sampled to determine the infection status. Sample size calculations to detect to disease or estimate prevalence of disease are dependent on the a priori prevalence of disease to be expected after introduction into a animal herd. The objective of this investigation was to describe the distribution of laboratory confirmed infection (serology and PCR) in infected cattle and sheep herds in the affected countries. Materials and Methods During the epidemic, animals within herds were sampled for laboratory confirmation of disease by serology and virus detection (PCR). In almost all herds, only animals with clinical signs were sampled. In a few herds a majority of animals were sampled in order to determine possible spread of the disease. This was for instance the case when animals for export, located outside restriction zones, were sampled to determine the BTV-disease status, as requested by the importing country. If such animals tested BTV-positive, all or a majority of animals in the herd of origin were tested. Furthermore, if a new case is found on considerable distance from the existing 2-km restriction zones, a higher proportion of animals within herds are sampled to have an indication of the disease status. Data on herd type (sheep or cattle), herd- or flocksize, number of serum samples for serological testing collected, the number of whole blood samples for PCR testing collected and the number of positive testing results for PCR and ELISA were obtained. In the analysis, we used data on PCR results on a herd level in cattle and sheep from Belgium (44 sheep flocks and 5 cattle herds), France (6 cattle herds), and the Netherlands (269 sheep flocks and 185 cattle herds), and serology data on a herd level in cattle and sheep from Belgium (282 sheep flocks and 25 cattle herds), France (6 cattle herds), and the Netherlands (26 sheep flocks and 183 cattle herds) with complete information on herdsize and presence or absence of clinical disease in animals from these farms. Since there were no follow-up investigations after the first clinical investigation, it can be anticipated that the number of animals PCR- and/or serology positive within flocks is actually higher than reported here. Results Since the results with respect to serology sampling were virtually identical to those of PCR sampling, we only show the serology results. Sheep Since in almost all cases only clinically sick animals were sampled at the time of clinical investigation, in the majority of sheep flocks only one to three sheep per flock were sampled, with a range of 1 to 78 sheep sampled within a flock (Figure 1). 2/9

In Figure 2 the distribution of % of sheep sampled within the flock (sheep sampled relative to flock size) in BTV-8 infected sheep flocks is shown. Since flock size of sheep flocks involved was fairly small (see results in section on Morbidity and Mortality), in combination with a small number of sheep sampled within a flock there was still a fair amount of variation in % of sheep sampled within flocks. In approximately 9% of the sheep flocks involved, almost all samples taken were seropositive (Figure 3). To get a more precise estimate of seroprevalence distribution in sheep flocks, we selected sheep flocks (flock size sheep) in which a considerable percentage of the animals present ( 5%) were sampled. In the four sheep flocks that met these criteria the seroprevalences in these flocks were 3%, 7%, 8%, and 22%. There was little difference in mean seroprevalence between flocks with and without clinical signs (Table 1). Table 1. Mean seroprevalence in sheep flocks with and without clinical signs. Sheep flocks No. Mean seroprevalence Mean % of sheep of flocks (%) sampled within flocks without clinical disease 75 23 2 with clinical disease 92 16 536 Cattle Since in almost all cases only clinically sick animals were sampled at the time of clinical investigation, in the majority of cattle herds only one to three head of cattle were sampled. Nevertheless, there were a small number of cattle herds in which a considerable number of cattle were sampled (Figure 4). In Figure 5 the distribution of % of cattle sampled within the herd (number of cattle sampled relative to herd size) in BTV-8 infected cattle herds is shown. Since herd size of cattle herds involved was rather large compared to the number of animals sampled within herds, only a small fraction of the animals was sampled. Only a small number of herds was sampled almost completely. In more than 8% of the cattle herds, almost all samples taken were seropositive (Figure 6). To get a more precise estimate of seroprevalence distribution in cattle herds, we selected cattle herds (herd size cattle) in which a considerable percentage of the animals present ( 5%) were sampled. This resulted in 27 cattle herds meeting the criteria. Crude seroprevalence within these flocks ranged from 1 to 76% (Figure 7). In Table 2 we can see that there is a difference in mean seroprevalence between flocks with and without clinical signs. However, it is highly probably that this is actually caused by the fact that in herds with clinical signs only the sick animals were sampled and in herds without clinical signs almost all animals within the herd. Table 2. Mean seroprevalence in cattle herds with and without clinical signs. Cattle herds No. Mean seroprevalence Mean % of cattle of herds (%) sampled within flocks without clinical disease 39 37 58 with clinical disease 397 94 7 3/9

Discussion and Conclusions There is very sparse information on serology and PCR results from animals sampled in suspected herds and flocks during outbreaks. Our results are comparable with outbreak reports in literature though. A cross-sectional study in Kazakhstan (without clinical suspicions) showed a within-herd seroprevalence in cattle, sheep and goats varying between and % between livestock owners (Lundervold et al. 23). Samples from cattle on the French Island of Reunion, collected a year before a clinical outbreak of epizootic haemorrhagic disease virus (EHDV) in cattle, indicated a % seroprevalence against BTV without clinical signs in these cattle (Breard et al. 25). Half a year after the EHDV outbreak, a sheep flock on this Island showed clinical disease signs indicative of BTV. Of 23 pyrexic Merino sheep with clinical signs, 18 were seropositive (78%), and 13 PCR-positive (68%) out of 19 sampled. During a BTV-outbreak in Turkey in 1999, involving serotype 9 and 16, cattle in villages with clinical disease were sampled. Of the eight villages sampled, seroprevalence in cattle was 75% or higher in five villages (Erturk et al. 24). The apparent high seroprevalence in cattle and low seroprevalence in sheep in our study might reflect that at least some species of the insect vector preferentially feed on cattle; as opposed to other ruminants (Erasmus 1975; Ward 1994). BTV is likely maintained by a cycle of infection in the insect vector and cattle, and only when the vector population is very abundant does virus spill over into other species such as sheep (MacLachlan 1994). In almost all cases only clinically sick animals (a total of one to three animals per herd) were sampled at the time of clinical investigation, in majority all these animals turned up positive by PCR and/or serology. Since there were no follow-up clinical investigations after the first clinical investigation to confirm infection, it can be anticipated that the final number of animals PCR- or serology-positive within herds and flocks is higher than reported here. On the basis of the sparse data from the whole-herd-sampling there is a tendency suggesting that a high proportion of cattle are PCR and/or serology positive within cattle herds a small proportion of sheep are PCR and/or serology positive within sheep flocks This is supported by the first impressions from the longitudinal field study in the Netherlands in five cattle herds and five sheep flocks. In herds (almost exclusively cattle herds) without clinical signs still a high proportion of PCR and/or serology positive animals can be found. Based on the above findings one can conclude that: since infected sheep clearly show disease by expression of clinical signs but there is a tendency that only a few sheep within a flock are PCR or serologically positive, a monitoring system based on clinical signs appears to be the better option for sheep flocks; since in infected cattle herds only a small portion (if any) of the animals tend to express clinical signs of the disease, but a large proportion of cattle are PCR and seropositive in infected cattle herds (even when no clinical signs at all are seen), a monitoring system based on serological screening of cattle seems to be more effective in cattle herds. 4/9

References Breard E, Sailleau C, Hamblin C, Zientara S 25. Bluetongue virus in the French Island of Reunion. Vet. Microbiol. 6: 157-165. Erasmus BJ 1975. Bluetongue in sheep and goats. Aust. Vet. J. 51: 165-17. Erturk A, Tatar N, Kabakli O, Incoglu S, Cizmeci SG, Barut FM 24. The currentc situation of Bluetongue in Turkey. Vet. Ital. 4: 137-14. Lundervold M, Milner-Gulland EJ, O callaghan CJ, Hamblin C 23. First eveidence of bluetongue virus in Kazakhstan. Vet. Microbiol. 92: 281-287. MacLachlan NJ 1994. The pathogenesis and immunology of bluetongue virus infection of ruminants. Comp. Immun. Microbiol. infect. Dis. 17: 197-26. Ward MP 1994. The epidemiology of bluetongue virus in Australia a review. Aust. Vet. J. 71: 3-7. 5/9

8 7 6 5 4 3 2 1 2 3 4 5 6-11 - 15 16-2 21-25 26-3 31-4 41-5 51-6 61-7 71-8 % sheep flocks (N = 542) Number of sheep sampled per flock for serological testing Figure 1 Distribution of number of serological samples per flock in BTV-8 infected sheep flocks from Belgium and The Netherlands. 35 % sheep flocks (N = 542) 3 25 2 15 5 1-5 6-11 - 2 21-3 31-4 41-5 51-6 61-7 71-8 81-9 91 - % sheep sampled within sheep flock Figure 2 Distribution of % of sheep sampled within the flock (sheep sampled relative to flock size) in BTV-8 infected sheep flocks from Belgium and The Netherlands. 6/9

% sheep flocks (N = 542) 9 8 7 6 5 4 3 2 1-2 21-4 41-6 61-8 81 - % seropostive samples per flock Figure 3 Distribution of % of seropositive samples within the flock in BTV-8 infected sheep flocks from Belgium and The Netherlands. 7 % cattle herds (N = 439) 6 5 4 3 2 1 2 3 4 5 6-11 - 15 16-2 21-4 41-6 61-8 81-1 - 15 151-2 21-25 Number of cattle sampled per herd for serological testing Figure 4 Distribution of number of serological samples per herd in BTV-8 infected cattle herds from Belgium, France and The Netherlands. 7/9

7 6 5 4 3 2 1-5 6-11 - 2 21-3 31-4 41-5 51-6 61-7 71-8 81-9 % cattle herds (N = 439) 91 - % of cattle sampled within herd Figure 5 Distribution of % of cattle sampled within the herd (cattle sampled relative to herd size) in BTV-8 infected cattle herds from Belgium, France and The Netherlands. % cattle herds (N = 439) 9 8 7 6 5 4 3 2 1-2 21-4 41-6 61-8 81 - % of seropositive samples per cattle herd Figure 6 Distribution of % of seropositive samples within the herd in BTV-8 infected cattle herds from Belgium, France and The Netherlands. 8/9

cattle herds (N = 27) with herdsize bigger or equal to cattle in which 5% or more of cattle were sampled % cattle herds 45 4 35 3 25 2 15 5 1-11 - 2 21-3 31-4 41-5 51-6 61-7 71-8 % seropositive samples within herd Figure 7 Distribution of seroprevalence within cattle herd in BTV-8 infected cattle herds with a herd size cattle and in which 5% of the cattle were sampled. 9/9